Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Biotechnology Research
Parkville, VIC-based SYNthesis med chem operates in Biotechnology Research. Privately held, at synmedchem.com. Five addresses sit on record, spread over four office countries. It employs 15 people, on the record. Its work is tagged medical Chemistry, discovery Project Management and hit to Lead and Lead Optimization. Two Australian registrations (ABN) are candidate matches. It is listed alongside four similar brands, mostly in Biotechnology Research.
ABN59166305111
ABN67126468228
| SYNTHESIS MED CHEM (AUSTRALIA) PTY LTD | ABN 59166305111 |
|---|---|
| SYNTHESIS MED CHEM PTY LTD | ABN 67126468228 |
| Confirmed matches | 0 of 2 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
SYNthesis (www.synmedchem.com) is a chemistry-focussed, contract research organisation providing custom synthesis and medicinal chemistry services.
The company was established in 2007 and operates a unique, hybrid business model combining medicinal chemistry & project management expertise based in both Australia and the USA, with high quality synthetic chemistry based in China.
In addition to Melbourne (Australia) where SYNthesis med chem's global headquarters are located, the company also has operations in Shanghai & Suzhou (China) together with offices in the UK and USA.
SYNthesis currently employs over 250 chemists based in Australia, China & the USA.
Our medicinal chemists provide the design, innovation, creativity and problem solving expertise required to complement the skills & capabilities of the company's expert team of synthetic chemists based in China.
Our medicinal chemists are all experienced and highly skilled scientists with a track record of delivering clinical candidates, a passion for discovering new medicines and a comprehensive insight gained from managing more than 100 projects covering all phases of the pharmaceutical R&D process.
They also act as project managers for custom synthesis and medicinal chemistry projects.
| Countries | 4 |
|---|---|
| Primary country | AU |
All codes: AU CN GB US
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
The people relation is never requested, so there is nothing here to unlock.
Two Victoria entities on the ABR: SYNTHESIS MED CHEM (AUSTRALIA) PTY LTD (ABN 59 166 305 111) and SYNTHESIS MED CHEM PTY LTD (ABN 67 126 468 228). Both medium confidence.
15 counted staff profiles at January 2026. The brand's self-reported band sits above that count and is not published as a headcount.
Five addresses on record across 4 countries. Primary: Bio21 Institute, Flemington Road, Parkville, VIC 3052.
None linked to this brand.
Five tags on the brand's own list, among them Medical Chemistry, Discovery Project Management and Hit to Lead and Lead Optimization.
Four peer profiles on record: SYNthesis Research and SYNthesis BioVentures.